jagomart
digital resources
picture1_Company Presentation Templates 66748 | Pao Breakout 3


 46x       Filetype PPTX       File size 0.06 MB       Source: cdp.cancer.gov


File: Company Presentation Templates 66748 | Pao Breakout 3
clinical ethics and regulatory aspects breakout assigning treatment based on ngs results in clinical trials sensitivity specificity nothing that was specific to ngs ie rules for current molecular tests still ...

icon picture PPTX Filetype Power Point PPTX | Posted on 28 Aug 2022 | 4 years ago
Partial capture of text on file.

						
									
										
									
																
													
					
The words contained in this file might help you see if this file matches what you are looking for:

...Clinical ethics and regulatory aspects breakout assigning treatment based on ngs results in trials sensitivity specificity nothing that was specific to ie rules for current molecular tests still apply reports should state tumor cellularity allele frequency need follow pts with low high frequencies dose of gene mutation vs drug response be followed studies registry public private partnership what evidence is needed act an result from a patient secondary evaluation controversial because it s not clear if the would as sensitive feasible have pre validated cap clia certified test every will found also no way company perform everything device or assay according fda whole thing including analytics bioinformatics how do we assess comparability different assays etc profiency panel approach adequate two initiatives cdc hapmap cell lines being deep sequenced by multiple groups data pooled able purchased coriel nist generating reference material genome sequencing neither has minimal proficiency s...

no reviews yet
Please Login to review.